Disc Medicine holder to sell 912 shares
Disc Medicine, Inc. (IRON) received a notice that Atlas Venture Opportunity Fund I plans to sell 912 shares of its common stock under Rule 144 through Merrill Lynch.
Rhea-AI Filing Summary
Disc Medicine, Inc. (IRON) received a notice that Atlas Venture Opportunity Fund I plans to sell 912 shares of its common stock under Rule 144 through Merrill Lynch. The shares were acquired in a private placement from the issuer on May 1, 2020 for cash.
The planned sale has an aggregate market value of $72,385.44. As context, 38,392,844 shares of Disc Medicine common stock were outstanding as of September 4, 2026; this is a baseline figure, not the amount being offered.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold under Rule 144: 912 shares
Aggregate market value: $72,385.44
Shares outstanding: 38,392,844 shares
+2 more
5 metrics
Shares to be sold under Rule 144
912 shares
Planned sale of Disc Medicine, Inc. common stock by Atlas Venture Opportunity Fund I
Aggregate market value
$72,385.44
Value of 912 Disc Medicine, Inc. shares covered by the Rule 144 notice
Shares outstanding
38,392,844 shares
Disc Medicine, Inc. common stock outstanding as of September 4, 2026
Acquisition date of shares
May 1, 2020
Date the 912 shares were acquired in a private placement from the issuer
Date of Rule 144 notice
September 4, 2026
Date the notice of proposed sale was given
Key Terms
Rule 144, aggregate market value, Private Placement, common stock
4 terms
Rule 144 regulatory
"plans to sell 912 shares of its common stock under Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
aggregate market value financial
"The planned sale has an aggregate market value of $72,385.44"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Private Placement financial
"The shares were acquired in a private placement from the issuer"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
common stock financial
"912 shares of its common stock under Rule 144"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What does the Form 144 notice report for Disc Medicine (IRON)?
It reports that Atlas Venture Opportunity Fund I plans to sell 912 shares of Disc Medicine, Inc. common stock under Rule 144, with an aggregate market value of $72,385.44, through Merrill Lynch.
AI-generated analysis. How Rhea-AI works. Not financial advice.
